Viking Therapeutics Inc (VKTX)’s stock is trading at $61.70 at the moment marking a fall of -1.37% from the last session close. As of this writing, shares are priced at -37.93% less than their 52-week high of $99.41, and 645.17% over their 52-week low of $8.28. Based on the past 30-day period, the stock price is -39.07% below the high and +77.94% above the low.
The 200-day Simple moving average is often placed more emphasis on by traders because of daily price changes. Investors will use the SMA-200 in different situations in trading activity as a key indicator to determine their support and resistance levels, and at the moment, VKTX’s SMA-200 is $21.44.
VKTX’s price to book ratio for the most recent quarter was 17.73, resulting in an 18.64 price to cash per share for the period.
How does Viking Therapeutics Inc (VKTX) stock rate among analysts? Buy, sell, or hold?
The key to trading is to concentrate on the future rather than on the past. During uncertain times, it can be hard to make decisions. The analysts who understand how a market works are usually the most accurate at forecasting its future. Currently, there are 10 brokerage firms that recommend the stock as a Strong Buy. The ratings are commonly aggregated into a single number between 1 and 5. Buy or strong buy is scored 5, outperform is scored 4, hold is scored 3, underperform is scored 2 and strong sell is 1. Using a scale of 1-5, the current average recommendation is 4.90 in simple terms.
Viking Therapeutics Inc (VKTX): Earnings History
If we examine Viking Therapeutics Inc’s recent earnings history, in the last quarter ended on 12/30/2023, it posted adjusted earnings per share of -$0.25, slashing the consensus of -$0.25. In other words, it beat the consensus by $0, resulting in a 0.00% surprise. In the 3 months period before the previous quarter which was closed on 12/30/2023, the stock recorded adjusted earnings per share of -$0.25 in contrast with the Outlook of -$0.25. That was a difference of $0 and a surprise of 0.00%.
Viking Therapeutics Inc (VKTX): Earnings History
Most analysts expect public companies to report earnings and revenue in line with their projections, but sometimes these figures vary from what they actually expected. In the current quarter, the company had earnings predictions made by 7 different analysts, who are expecting earnings to fall in between the range of -0.24 and -0.32 with an average Earnings Estimate of -0.27 which is in contrast with the last year earnings estimate of -0.25 and also replicates -8.00% growth rate year over year.
Viking Therapeutics Inc (NASDAQ: VKTX) Ownership Details
I will give a breakdown of the key shareholders in Viking Therapeutics Inc (VKTX). Recent figures show that the company’s insiders hold 5.46% of shares. A total of 279 institutional investors hold shares in the company, making 73.60% of its stock and 77.85% of its float.
Jun 29, 2023, it was reported that the Company’s largest institutional holder is FMR, LLC holding total of 14.98 million shares that make 14.97% of the company’s total number of shares and are currently priced at 242.76 million.
The securities firm Blackrock Inc. holds 6.89 million shares of VKTX, making it the second largest institutional shareholder. Taking this into account, the holding percentage comes to 6.89%, and the holding percentage of shares is valued at 111.77 million.
An overview of Viking Therapeutics Inc’s technicals
In order to learn about trade movements and investor behavior, it is best to analyze the short, medium, and long term technical indicators along with the average volume of a stock. A 20-day average of the stock’s daily volume suggests Viking Therapeutics Inc (VKTX) traded 12,018,590 shares per day, with a moving average of $66.56 and price change of +24.37. With the moving average of $41.31 and a price change of +41.99, about 6,862,746 shares changed hands on average over the past 50 days. Finally, VKTX’s 100-day average volume is 4,691,902 shares, alongside a moving average of $27.70 and a price change of +50.19.
